SSG
TMO icon

Summit Securities Group’s Thermo Fisher Scientific TMO Stock Holding History

Summit Securities Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,200
Closed -$2.23M – 881
2023
Q4 		$2.23M Buy
+4,200
New +$2.03M 0.2% 82
2021
Q4 		– Sell
-8
Closed -$457K – 944
2021
Q3 		$457K Sell
8
-9
-53% -$4.94K 0.04% 418
2021
Q2 		$858K Buy
+17
New +$8.02K 0.07% 279

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Summit Securities Group's TMO Position: Q2 2026 in Review

Summit Securities Group increased its Thermo Fisher Scientific (TMO) stake by 39% in Q2 2026, buying an estimated $11.5K and bringing the position to 86 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #606.

Summit Securities Group first reported a position in TMO in Q2 2015 and has held it in 12 quarters since. The position peaked at $444K in Q1 2023. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Summit Securities Group held 86 shares of Thermo Fisher Scientific worth $43.1K as of Q2 2026.
  • Summit Securities Group bought 24 Thermo Fisher Scientific shares in Q2 2026, an estimated $11.5K.
  • Thermo Fisher Scientific made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #606 holding.
  • Summit Securities Group first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 12 quarters since.
  • Summit Securities Group's Thermo Fisher Scientific position peaked at $444K in Q1 2023.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.